8GHD

The structure of h12-LOX in hexameric form bound to inhibitor ML355 and arachidonic acid

Summary for 8GHD

Entry DOI	10.2210/pdb8ghd/pdb
EMDB information	40041 40302 40304
Descriptor	Polyunsaturated fatty acid lipoxygenase ALOX12, FE (II) ION, N-(1,3-benzothiazol-2-yl)-4-{[(2-hydroxy-3-methoxyphenyl)methyl]amino}benzene-1-sulfonamide, ... (4 entities in total)
Functional Keywords	lipoxygenase, platelets, lipid-modifying enzyme, lipid oxidation, oxidoreductase, oxidoreductase-inhibitor complex, oxidoreductase/inhibitor
Biological source	Homo sapiens (human)
Total number of polymer chains	6
Total formula weight	464307.23
Authors	Black, K.A.,Mobbs, J.I.,Venugopal, H.,Thal, D.M.,Glukhova, A. (deposition date: 2023-03-09, release date: 2023-08-09, Last modification date: 2023-10-11)
Primary citation	Mobbs, J.I.,Black, K.A.,Tran, M.,Burger, W.A.C.,Venugopal, H.,Holman, T.R.,Holinstat, M.,Thal, D.M.,Glukhova, A. Cryo-EM structures of human arachidonate 12S-lipoxygenase bound to endogenous and exogenous inhibitors. Blood, 142:1233-1242, 2023 Cited by PubMed: 37506345 DOI: 10.1182/blood.2023020441 PDB entries with the same primary citation
Experimental method	ELECTRON MICROSCOPY (2.2 Å)

Structure validation